Alamar Biosciences Launches Nasdaq IPO, Boosting Biotech Innovation & Investor Interest
Alamar Biosciences’ Nasdaq IPO boosts biotech innovation, unlocking $1.63B capital to accelerate novel therapies and attract strategic partnerships.
2 minutes to read